Search research articles
Contact Us
Filters
Showing results (781-790 of 829) with videos related to
Page
of 83
Sort By:
Hepatology International
|
May 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus
Young-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2020
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
Michael A Postow, Susan J Knox, Debra A Goldman, et al.
Science Advances
|
September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability
Manuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
Gastroenterology
|
November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
Chun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia
Dalton King, Christiana Iwuagwu, Jim Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
Joanna M Karasinska, James T Topham, Steve E Kalloger, et al.
JCO Clinical Cancer Informatics
|
April 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer
Avelyn Wong, Taib A Bourega, Rémy Nicolle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial
Tanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.
The Lancet. Infectious Diseases
|
April 13, 2015
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Page
of 83
Search research articles
Search
Showing results (781-790 of 829) with videos related to
Sort By:
Page
of 83
Hepatology International
|
May 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus
Young-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2020
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
Michael A Postow, Susan J Knox, Debra A Goldman, et al.
Science Advances
|
September 1, 2023
BRAF<sup>Δβ3-αC</sup> in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability
Manuel Lauinger, Daniel Christen, Rhena F U Klar, et al.
Gastroenterology
|
November 28, 2017
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
Chun-Jen Liu, Wan-Long Chuang, I-Shyan Sheen, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia
Dalton King, Christiana Iwuagwu, Jim Cook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2019
Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
Joanna M Karasinska, James T Topham, Steve E Kalloger, et al.
JCO Clinical Cancer Informatics
|
April 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer
Avelyn Wong, Taib A Bourega, Rémy Nicolle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial
Tanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.
The Lancet. Infectious Diseases
|
April 13, 2015
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2020
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M O'Kane, Barbara T Grünwald, Gun-Ho Jang, et al.
Page
of 83